Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5

Daniel K. Nolan, Beth Sutton, Carol Haynes, Jessica Johnson, Jacqueline Sebek, Elaine Dowdy, David Crosslin, David Crossman, Michael H. Sketch, Christopher B. Granger, David M Seo, Pascal Goldschmidt-Clermont, William E. Kraus, Simon G. Gregory, Elizabeth R. Hauser, Svati H. Shah

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Coronary artery disease (CAD), and one of its intermediate risk factors, dyslipidemia, possess a demonstrable genetic component, although the genetic architecture is incompletely defined. We previously reported a linkage peak on chromosome 5q31-33 for early-onset CAD where the strength of evidence for linkage was increased in families with higher mean low density lipoprotein-cholesterol (LDL-C). Therefore, we sought to fine-map the peak using association mapping of LDL-C as an intermediate disease-related trait to further define the etiology of this linkage peak. The study populations consisted of 1908 individuals from the CATHGEN biorepository of patients undergoing cardiac catheterization; 254 families (N = 827 individuals) from the GENECARD familial study of early-onset CAD; and 162 aorta samples harvested from deceased donors. Linkage disequilibrium-tagged SNPs were selected with an average of one SNP per 20 kb for 126.6-160.2 MB (region of highest linkage) and less dense spacing (one SNP per 50 kb) for the flanking regions (117.7-126.6 and 160.2-167.5 MB) and genotyped on all samples using a custom Illumina array. Association analysis of each SNP with LDL-C was performed using multivariable linear regression (CATHGEN) and the quantitative trait transmission disequilibrium test (QTDT; GENECARD). SNPs associated with the intermediate quantitative trait, LDL-C, were then assessed for association with CAD (i.e., a qualitative phenotype) using linkage and association in the presence of linkage (APL; GENECARD) and logistic regression (CATHGEN and aortas).Results: We identified four genes with SNPs that showed the strongest and most consistent associations with LDL-C and CAD: EBF1, PPP2R2B, SPOCK1, and PRELID2. The most significant results for association of SNPs with LDL-C were: EBF1, rs6865969, p = 0.01; PPP2R2B, rs2125443, p = 0.005; SPOCK1, rs17600115, p = 0.003; and PRELID2, rs10074645, p = 0.0002). The most significant results for CAD were EBF1, rs6865969, p = 0.007; PPP2R2B, rs7736604, p = 0.0003; SPOCK1, rs17170899, p = 0.004; and PRELID2, rs7713855, p = 0.003.Conclusion: Using an intermediate disease-related quantitative trait of LDL-C we have identified four novel CAD genes, EBF1, PRELID2, SPOCK1, and PPP2R2B. These four genes should be further examined in future functional studies as candidate susceptibility loci for cardiovascular disease mediated through LDL-cholesterol pathways.

Original languageEnglish
Article number12
JournalBMC Genetics
Volume13
DOIs
StatePublished - Feb 27 2012

Fingerprint

Chromosomes, Human, Pair 5
Chromosome Mapping
LDL Cholesterol
Coronary Artery Disease
Single Nucleotide Polymorphism
Lipids
Genes
Aorta
Linkage Disequilibrium
Cardiac Catheterization
Dyslipidemias
Linear Models
Cardiovascular Diseases
Chromosomes
Logistic Models
Tissue Donors
Phenotype

Keywords

  • Cardiovascular disease
  • Fine mapping
  • Intermediate phenotype
  • Linkage
  • Positional cloning

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. / Nolan, Daniel K.; Sutton, Beth; Haynes, Carol; Johnson, Jessica; Sebek, Jacqueline; Dowdy, Elaine; Crosslin, David; Crossman, David; Sketch, Michael H.; Granger, Christopher B.; Seo, David M; Goldschmidt-Clermont, Pascal; Kraus, William E.; Gregory, Simon G.; Hauser, Elizabeth R.; Shah, Svati H.

In: BMC Genetics, Vol. 13, 12, 27.02.2012.

Research output: Contribution to journalArticle

Nolan, DK, Sutton, B, Haynes, C, Johnson, J, Sebek, J, Dowdy, E, Crosslin, D, Crossman, D, Sketch, MH, Granger, CB, Seo, DM, Goldschmidt-Clermont, P, Kraus, WE, Gregory, SG, Hauser, ER & Shah, SH 2012, 'Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5', BMC Genetics, vol. 13, 12. https://doi.org/10.1186/1471-2156-13-12
Nolan, Daniel K. ; Sutton, Beth ; Haynes, Carol ; Johnson, Jessica ; Sebek, Jacqueline ; Dowdy, Elaine ; Crosslin, David ; Crossman, David ; Sketch, Michael H. ; Granger, Christopher B. ; Seo, David M ; Goldschmidt-Clermont, Pascal ; Kraus, William E. ; Gregory, Simon G. ; Hauser, Elizabeth R. ; Shah, Svati H. / Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. In: BMC Genetics. 2012 ; Vol. 13.
@article{c1f14643a2ce479584dfd98770ef2da7,
title = "Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5",
abstract = "Background: Coronary artery disease (CAD), and one of its intermediate risk factors, dyslipidemia, possess a demonstrable genetic component, although the genetic architecture is incompletely defined. We previously reported a linkage peak on chromosome 5q31-33 for early-onset CAD where the strength of evidence for linkage was increased in families with higher mean low density lipoprotein-cholesterol (LDL-C). Therefore, we sought to fine-map the peak using association mapping of LDL-C as an intermediate disease-related trait to further define the etiology of this linkage peak. The study populations consisted of 1908 individuals from the CATHGEN biorepository of patients undergoing cardiac catheterization; 254 families (N = 827 individuals) from the GENECARD familial study of early-onset CAD; and 162 aorta samples harvested from deceased donors. Linkage disequilibrium-tagged SNPs were selected with an average of one SNP per 20 kb for 126.6-160.2 MB (region of highest linkage) and less dense spacing (one SNP per 50 kb) for the flanking regions (117.7-126.6 and 160.2-167.5 MB) and genotyped on all samples using a custom Illumina array. Association analysis of each SNP with LDL-C was performed using multivariable linear regression (CATHGEN) and the quantitative trait transmission disequilibrium test (QTDT; GENECARD). SNPs associated with the intermediate quantitative trait, LDL-C, were then assessed for association with CAD (i.e., a qualitative phenotype) using linkage and association in the presence of linkage (APL; GENECARD) and logistic regression (CATHGEN and aortas).Results: We identified four genes with SNPs that showed the strongest and most consistent associations with LDL-C and CAD: EBF1, PPP2R2B, SPOCK1, and PRELID2. The most significant results for association of SNPs with LDL-C were: EBF1, rs6865969, p = 0.01; PPP2R2B, rs2125443, p = 0.005; SPOCK1, rs17600115, p = 0.003; and PRELID2, rs10074645, p = 0.0002). The most significant results for CAD were EBF1, rs6865969, p = 0.007; PPP2R2B, rs7736604, p = 0.0003; SPOCK1, rs17170899, p = 0.004; and PRELID2, rs7713855, p = 0.003.Conclusion: Using an intermediate disease-related quantitative trait of LDL-C we have identified four novel CAD genes, EBF1, PRELID2, SPOCK1, and PPP2R2B. These four genes should be further examined in future functional studies as candidate susceptibility loci for cardiovascular disease mediated through LDL-cholesterol pathways.",
keywords = "Cardiovascular disease, Fine mapping, Intermediate phenotype, Linkage, Positional cloning",
author = "Nolan, {Daniel K.} and Beth Sutton and Carol Haynes and Jessica Johnson and Jacqueline Sebek and Elaine Dowdy and David Crosslin and David Crossman and Sketch, {Michael H.} and Granger, {Christopher B.} and Seo, {David M} and Pascal Goldschmidt-Clermont and Kraus, {William E.} and Gregory, {Simon G.} and Hauser, {Elizabeth R.} and Shah, {Svati H.}",
year = "2012",
month = "2",
day = "27",
doi = "10.1186/1471-2156-13-12",
language = "English",
volume = "13",
journal = "BMC Genetics",
issn = "1471-2156",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5

AU - Nolan, Daniel K.

AU - Sutton, Beth

AU - Haynes, Carol

AU - Johnson, Jessica

AU - Sebek, Jacqueline

AU - Dowdy, Elaine

AU - Crosslin, David

AU - Crossman, David

AU - Sketch, Michael H.

AU - Granger, Christopher B.

AU - Seo, David M

AU - Goldschmidt-Clermont, Pascal

AU - Kraus, William E.

AU - Gregory, Simon G.

AU - Hauser, Elizabeth R.

AU - Shah, Svati H.

PY - 2012/2/27

Y1 - 2012/2/27

N2 - Background: Coronary artery disease (CAD), and one of its intermediate risk factors, dyslipidemia, possess a demonstrable genetic component, although the genetic architecture is incompletely defined. We previously reported a linkage peak on chromosome 5q31-33 for early-onset CAD where the strength of evidence for linkage was increased in families with higher mean low density lipoprotein-cholesterol (LDL-C). Therefore, we sought to fine-map the peak using association mapping of LDL-C as an intermediate disease-related trait to further define the etiology of this linkage peak. The study populations consisted of 1908 individuals from the CATHGEN biorepository of patients undergoing cardiac catheterization; 254 families (N = 827 individuals) from the GENECARD familial study of early-onset CAD; and 162 aorta samples harvested from deceased donors. Linkage disequilibrium-tagged SNPs were selected with an average of one SNP per 20 kb for 126.6-160.2 MB (region of highest linkage) and less dense spacing (one SNP per 50 kb) for the flanking regions (117.7-126.6 and 160.2-167.5 MB) and genotyped on all samples using a custom Illumina array. Association analysis of each SNP with LDL-C was performed using multivariable linear regression (CATHGEN) and the quantitative trait transmission disequilibrium test (QTDT; GENECARD). SNPs associated with the intermediate quantitative trait, LDL-C, were then assessed for association with CAD (i.e., a qualitative phenotype) using linkage and association in the presence of linkage (APL; GENECARD) and logistic regression (CATHGEN and aortas).Results: We identified four genes with SNPs that showed the strongest and most consistent associations with LDL-C and CAD: EBF1, PPP2R2B, SPOCK1, and PRELID2. The most significant results for association of SNPs with LDL-C were: EBF1, rs6865969, p = 0.01; PPP2R2B, rs2125443, p = 0.005; SPOCK1, rs17600115, p = 0.003; and PRELID2, rs10074645, p = 0.0002). The most significant results for CAD were EBF1, rs6865969, p = 0.007; PPP2R2B, rs7736604, p = 0.0003; SPOCK1, rs17170899, p = 0.004; and PRELID2, rs7713855, p = 0.003.Conclusion: Using an intermediate disease-related quantitative trait of LDL-C we have identified four novel CAD genes, EBF1, PRELID2, SPOCK1, and PPP2R2B. These four genes should be further examined in future functional studies as candidate susceptibility loci for cardiovascular disease mediated through LDL-cholesterol pathways.

AB - Background: Coronary artery disease (CAD), and one of its intermediate risk factors, dyslipidemia, possess a demonstrable genetic component, although the genetic architecture is incompletely defined. We previously reported a linkage peak on chromosome 5q31-33 for early-onset CAD where the strength of evidence for linkage was increased in families with higher mean low density lipoprotein-cholesterol (LDL-C). Therefore, we sought to fine-map the peak using association mapping of LDL-C as an intermediate disease-related trait to further define the etiology of this linkage peak. The study populations consisted of 1908 individuals from the CATHGEN biorepository of patients undergoing cardiac catheterization; 254 families (N = 827 individuals) from the GENECARD familial study of early-onset CAD; and 162 aorta samples harvested from deceased donors. Linkage disequilibrium-tagged SNPs were selected with an average of one SNP per 20 kb for 126.6-160.2 MB (region of highest linkage) and less dense spacing (one SNP per 50 kb) for the flanking regions (117.7-126.6 and 160.2-167.5 MB) and genotyped on all samples using a custom Illumina array. Association analysis of each SNP with LDL-C was performed using multivariable linear regression (CATHGEN) and the quantitative trait transmission disequilibrium test (QTDT; GENECARD). SNPs associated with the intermediate quantitative trait, LDL-C, were then assessed for association with CAD (i.e., a qualitative phenotype) using linkage and association in the presence of linkage (APL; GENECARD) and logistic regression (CATHGEN and aortas).Results: We identified four genes with SNPs that showed the strongest and most consistent associations with LDL-C and CAD: EBF1, PPP2R2B, SPOCK1, and PRELID2. The most significant results for association of SNPs with LDL-C were: EBF1, rs6865969, p = 0.01; PPP2R2B, rs2125443, p = 0.005; SPOCK1, rs17600115, p = 0.003; and PRELID2, rs10074645, p = 0.0002). The most significant results for CAD were EBF1, rs6865969, p = 0.007; PPP2R2B, rs7736604, p = 0.0003; SPOCK1, rs17170899, p = 0.004; and PRELID2, rs7713855, p = 0.003.Conclusion: Using an intermediate disease-related quantitative trait of LDL-C we have identified four novel CAD genes, EBF1, PRELID2, SPOCK1, and PPP2R2B. These four genes should be further examined in future functional studies as candidate susceptibility loci for cardiovascular disease mediated through LDL-cholesterol pathways.

KW - Cardiovascular disease

KW - Fine mapping

KW - Intermediate phenotype

KW - Linkage

KW - Positional cloning

UR - http://www.scopus.com/inward/record.url?scp=84857410607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857410607&partnerID=8YFLogxK

U2 - 10.1186/1471-2156-13-12

DO - 10.1186/1471-2156-13-12

M3 - Article

C2 - 22369142

AN - SCOPUS:84857410607

VL - 13

JO - BMC Genetics

JF - BMC Genetics

SN - 1471-2156

M1 - 12

ER -